331 related articles for article (PubMed ID: 29412107)
21. Antibiotics-Peptide Conjugates Against Multidrug-resistant Bacterial Pathogens.
David AA; Park SE; Parang K; Tiwari RK
Curr Top Med Chem; 2018; 18(22):1926-1936. PubMed ID: 30499392
[TBL] [Abstract][Full Text] [Related]
22. Multidrug resistant Acinetobacter baumannii--the role of AdeABC (RND family) efflux pump in resistance to antibiotics.
Wieczorek P; Sacha P; Hauschild T; Zórawski M; Krawczyk M; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(3):257-67. PubMed ID: 19056528
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic Resistant Superbugs: Assessment of the Interrelationship of Occurrence in Clinical Settings and Environmental Niches.
Adegoke AA; Faleye AC; Singh G; Stenström TA
Molecules; 2016 Dec; 22(1):. PubMed ID: 28035988
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of Antibiotic Resistance.
Munita JM; Arias CA
Microbiol Spectr; 2016 Apr; 4(2):. PubMed ID: 27227291
[TBL] [Abstract][Full Text] [Related]
25. Strategies to prevent the occurrence of resistance against antibiotics by using advanced materials.
Bassegoda A; Ivanova K; Ramon E; Tzanov T
Appl Microbiol Biotechnol; 2018 Mar; 102(5):2075-2089. PubMed ID: 29392390
[TBL] [Abstract][Full Text] [Related]
26. Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
Bragonzi A
Sci Transl Med; 2010 Mar; 2(21):21ps9. PubMed ID: 20374995
[TBL] [Abstract][Full Text] [Related]
27. Ecology and Evolution of Chromosomal Gene Transfer between Environmental Microorganisms and Pathogens.
Martínez JL
Microbiol Spectr; 2018 Jan; 6(1):. PubMed ID: 29350130
[TBL] [Abstract][Full Text] [Related]
28. [Active efflux as the multidrug resistance mechanism].
Wasaznik A; Grinholc M; Bielawski KP
Postepy Hig Med Dosw (Online); 2009 Apr; 63():123-33. PubMed ID: 19373193
[TBL] [Abstract][Full Text] [Related]
29. Virulence-targeted Antibacterials: Concept, Promise, and Susceptibility to Resistance Mechanisms.
Ruer S; Pinotsis N; Steadman D; Waksman G; Remaut H
Chem Biol Drug Des; 2015 Oct; 86(4):379-99. PubMed ID: 25589217
[TBL] [Abstract][Full Text] [Related]
30. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
31. Something old, something new: revisiting natural products in antibiotic drug discovery.
Wright GD
Can J Microbiol; 2014 Mar; 60(3):147-54. PubMed ID: 24588388
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic resistance: from Darwin to Lederberg to Keynes.
Amábile-Cuevas CF
Microb Drug Resist; 2013 Apr; 19(2):73-87. PubMed ID: 23046150
[TBL] [Abstract][Full Text] [Related]
33. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
Gootz TD
Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
[TBL] [Abstract][Full Text] [Related]
34. Antibiotics and antibiotic resistance genes in natural environments.
Martínez JL
Science; 2008 Jul; 321(5887):365-7. PubMed ID: 18635792
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.
Rouveix B
J Antimicrob Chemother; 2007 Jun; 59(6):1208-9. PubMed ID: 17507420
[TBL] [Abstract][Full Text] [Related]
36. Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review.
Saadeh HA; Mubarak MS
Curr Top Med Chem; 2017; 17(8):895-906. PubMed ID: 27697051
[TBL] [Abstract][Full Text] [Related]
37. The antibiotic resistome: the nexus of chemical and genetic diversity.
Wright GD
Nat Rev Microbiol; 2007 Mar; 5(3):175-86. PubMed ID: 17277795
[TBL] [Abstract][Full Text] [Related]
38. Efflux drug transporters at the forefront of antimicrobial resistance.
Rahman T; Yarnall B; Doyle DA
Eur Biophys J; 2017 Oct; 46(7):647-653. PubMed ID: 28710521
[TBL] [Abstract][Full Text] [Related]
39. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance.
Hughes D; Andersson DI
FEMS Microbiol Rev; 2017 May; 41(3):374-391. PubMed ID: 28333270
[TBL] [Abstract][Full Text] [Related]
40. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view.
Lynch AS
Biochem Pharmacol; 2006 Mar; 71(7):949-56. PubMed ID: 16290174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
